Integra LifeSciences Holdings Price to Sales Ratio 2010-2023 | IART
Historical PS ratio values for Integra LifeSciences Holdings (IART) over the last 10 years. The current P/S ratio for Integra LifeSciences Holdings as of April 22, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Integra LifeSciences Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-22 | 28.98 | 1.52 | |
| 2023-12-31 | 43.55 | $19.06 | 2.29 |
| 2023-09-30 | 38.19 | $18.88 | 2.02 |
| 2023-06-30 | 41.13 | $18.71 | 2.20 |
| 2023-03-31 | 57.41 | $18.77 | 3.06 |
| 2022-12-31 | 56.07 | $18.61 | 3.01 |
| 2022-09-30 | 42.36 | $18.59 | 2.28 |
| 2022-06-30 | 54.03 | $18.50 | 2.92 |
| 2022-03-31 | 64.26 | $18.31 | 3.51 |
| 2021-12-31 | 66.99 | $18.06 | 3.71 |
| 2021-09-30 | 68.48 | $17.88 | 3.83 |
| 2021-06-30 | 68.24 | $17.72 | 3.85 |
| 2021-03-31 | 69.09 | $16.21 | 4.26 |
| 2020-12-31 | 64.92 | $16.11 | 4.03 |
| 2020-09-30 | 47.22 | $16.12 | 2.93 |
| 2020-06-30 | 46.99 | $16.17 | 2.91 |
| 2020-03-31 | 44.67 | $17.57 | 2.54 |
| 2019-12-31 | 58.28 | $17.61 | 3.31 |
| 2019-09-30 | 60.07 | $17.61 | 3.41 |
| 2019-06-30 | 55.85 | $17.42 | 3.21 |
| 2019-03-31 | 55.72 | $17.36 | 3.21 |
| 2018-12-31 | 45.10 | $17.66 | 2.55 |
| 2018-09-30 | 65.87 | $17.76 | 3.71 |
| 2018-06-30 | 64.41 | $17.03 | 3.78 |
| 2018-03-31 | 55.34 | $16.21 | 3.41 |
| 2017-12-31 | 47.86 | $15.04 | 3.18 |
| 2017-09-30 | 50.48 | $13.61 | 3.71 |
| 2017-06-30 | 54.51 | $13.19 | 4.13 |
| 2017-03-31 | 42.13 | $12.78 | 3.30 |
| 2016-12-31 | 42.90 | $12.58 | 3.41 |
| 2016-09-30 | 41.28 | $12.73 | 3.24 |
| 2016-06-30 | 39.89 | $12.85 | 3.10 |
| 2016-03-31 | 33.68 | $12.82 | 2.63 |
| 2015-12-31 | 33.89 | $12.76 | 2.66 |
| 2015-09-30 | 29.78 | $11.70 | 2.55 |
| 2015-06-30 | 30.59 | $11.49 | 2.66 |
| 2015-03-31 | 28.00 | $11.88 | 2.36 |
| 2014-12-31 | 24.63 | $12.13 | 2.03 |
| 2014-09-30 | 22.54 | $11.22 | 2.01 |
| 2014-06-30 | 21.37 | $12.04 | 1.77 |
| 2014-03-31 | 20.88 | $12.17 | 1.72 |
| 2013-12-31 | 21.67 | $12.43 | 1.74 |
| 2013-09-30 | 18.28 | $14.77 | 1.24 |
| 2013-06-30 | 16.63 | $14.60 | 1.14 |
| 2013-03-31 | 17.71 | $14.62 | 1.21 |
| 2012-12-31 | 17.70 | $14.53 | 1.22 |
| 2012-09-30 | 18.66 | $14.22 | 1.31 |
| 2012-06-30 | 16.88 | $14.05 | 1.20 |
| 2012-03-31 | 15.75 | $13.58 | 1.16 |
| 2011-12-31 | 14.00 | $13.13 | 1.07 |
| 2011-09-30 | 16.24 | $12.90 | 1.26 |
| 2011-06-30 | 21.71 | $12.52 | 1.73 |
| 2011-03-31 | 21.53 | $12.26 | 1.76 |
| 2010-12-31 | 21.48 | $12.14 | 1.77 |
| 2010-09-30 | 17.92 | $12.05 | 1.49 |
| 2010-06-30 | 16.80 | $11.88 | 1.41 |
| 2010-03-31 | 19.90 | $11.78 | 1.69 |
| 2009-12-31 | 16.74 | $11.65 | 1.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.278B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $209.324B | 25.46 |
| Intuitive Surgical (ISRG) | United States | $130.862B | 78.83 |
| Edwards Lifesciences (EW) | United States | $52.344B | 34.65 |
| DexCom (DXCM) | United States | $50.703B | 87.10 |
| IQVIA Holdings (IQV) | United States | $41.988B | 24.90 |
| IDEXX Laboratories (IDXX) | United States | $39.830B | 47.62 |
| Alcon (ALC) | Switzerland | $39.749B | 29.31 |
| STERIS (STE) | Ireland | $19.852B | 23.50 |
| Hologic (HOLX) | United States | $17.891B | 19.75 |
| Waters (WAT) | United States | $17.747B | 25.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.624B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.289B | 84.91 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.059B | 14.89 |
| Sysmex ADR (SSMXY) | Japan | $9.956B | 31.22 |
| Teleflex (TFX) | United States | $9.763B | 15.33 |
| Penumbra (PEN) | United States | $7.857B | 97.13 |
| Masimo (MASI) | United States | $7.107B | 39.86 |
| Globus Medical (GMED) | United States | $6.938B | 22.00 |
| Glaukos (GKOS) | United States | $4.966B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.908B | 24.98 |
| LivaNova (LIVN) | United Kingdom | $2.914B | 19.22 |
| TransMedics (TMDX) | United States | $2.830B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.660B | 18.25 |
| PROCEPT BioRobotics (PRCT) | United States | $2.609B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
| Inari Medical (NARI) | United States | $2.198B | 379.30 |
| Tandem Diabetes Care (TNDM) | United States | $2.049B | 0.00 |
| RxSight (RXST) | United States | $1.936B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.765B | 0.00 |
| Veracyte (VCYT) | United States | $1.490B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.876B | 16.20 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| Artivion (AORT) | United States | $0.837B | 96.76 |
| Paragon 28 (FNA) | United States | $0.812B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.685B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.552B | 18.73 |
| IRadimed (IRMD) | United States | $0.536B | 31.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.489B | 0.00 |
| Nevro (NVRO) | United States | $0.450B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.378B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.348B | 11.72 |
| CVRx (CVRX) | United States | $0.317B | 0.00 |
| AxoGen (AXGN) | United States | $0.300B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.185B | 9.95 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.178B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.170B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.140B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.00 |
| Vasomedical (VASO) | United States | $0.051B | 9.17 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| DarioHealth (DRIO) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |